Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

Assessment and Diagnosis

  • AECOPD presents as worsening of previous stable situation with increased sputum purulence, increased sputum volume, increased dyspnea, increased wheeze, chest tightness, and/or fluid retention 1
  • Consider differential diagnoses including pneumonia, pneumothorax, left ventricular failure, pulmonary embolus, lung cancer, and upper airway obstruction 1
  • Determine severity of exacerbation to guide treatment setting (home vs. hospital) 3

Treatment Approach

Bronchodilator Therapy

  • Add or increase short-acting bronchodilators as first-line treatment 1, 4
  • Use beta-agonists (salbutamol 2.5-5 mg or terbutaline 5-10 mg) and/or anticholinergic drugs (ipratropium bromide 0.25-0.5 mg) 5, 6
  • Prefer inhaled route with appropriate device the patient can use effectively 1

Antibiotic Therapy

  • Initiate antibiotics if two or more of the following are present: increased breathlessness, increased sputum volume, or development of purulent sputum 1, 3
  • Antibiotics can shorten recovery time and reduce the risk of early relapse, treatment failure, and hospitalization duration 7
  • Duration of antibiotic therapy should be 5-7 days 7

Corticosteroid Therapy

  • Systemic corticosteroids improve lung function, oxygenation, and shorten recovery time and hospitalization duration 7
  • Recommended dose is prednisolone 30-40 mg per day for 5-7 days 1, 7

Oxygen Therapy

  • For hospitalized patients, provide controlled oxygen therapy to maintain oxygen saturation 3, 6
  • Target oxygen saturation should achieve PaO2 >7.5 kPa without causing respiratory acidosis 6

Management Based on Setting

Home Management

  • Goals: treat bacterial infection, remove excess secretions, increase maximum airflow, and improve respiratory muscle strength 3
  • Treatment components:

Hospital Management

  • Goals: evaluate severity, identify cause, provide controlled oxygenation, and return patient to best previous condition 3
  • Additional treatments may include:

Ventilatory Support

  • Consider non-invasive positive pressure ventilation (NIPPV) or invasive ventilation for patients with pH <7.26 and rising PaCO2 who fail to respond to supportive treatment 5
  • NIPPV has been shown to reduce the need for intubation and length of hospital stay 5

Follow-up Care

  • Review after an acute exacerbation to assess response to treatment 1
  • Use follow-up visit to help patient plan for future and prevent further exacerbations 1
  • Provide advice on smoking cessation, lifestyle, activity levels, weight, and review medication 1

Common Pitfalls and Caveats

  • Methylxanthines are not recommended as first-line therapy due to increased side effect profiles 7
  • Chest physiotherapy is not recommended in acute exacerbations of COPD 5
  • Consider patient's comorbidities and adjust treatment accordingly 7